Beijing Wansi Medical Technology
Vascular interventional surgical robots for minimally invasive procedures
About Beijing Wansi Medical Technology
Beijing Wansi Medical Technology Co., Ltd. is a high-tech enterprise focused on the research, development, production, and service of vascular interventional surgical robots and their associated consumables, particularly for neuro-interventional procedures. The company's name, 'Wansi,' is a phonetic translation of the Latin word for vessel, 'Vas'.
The company was founded in 2017 as an industrial-scale application of a key national research and development project. The founder and CEO is Professor Li Youxiang, a leading neuro-interventional expert from Beijing Tiantan Hospital, affiliated with Capital Medical University. He is recognized as the inventor of the world's first neuro-interventional AI system. Li Jin serves as the co-founder and COO. A significant milestone was achieved in 2019 when Professor Li's team completed the first robot-assisted whole-brain angiography in China. The company began large-scale multi-center clinical trials for its neurovascular interventional surgical robot in 2021 and received registration acceptance from China's National Medical Products Administration (NMPA) in 2023, marking 2024 as the start of its commercialization. In March 2023, Wansi Medical announced the completion of an angel financing round of 100 million RMB, co-led by Guoke Investment and Nuoyu Capital.
Wansi Medical's core product is the VAS HERO neuro-interventional surgical robot. This system uses a master-slave structure, allowing surgeons to operate from a control room, which protects them from radiation exposure and the physical strain of wearing lead aprons. The robotic platform is designed to enhance the surgeon's capabilities by providing stability and precision in manipulating catheters and guidewires. The company also provides comprehensive intelligent surgical solutions that include AI-assisted preoperative planning, real-time intraoperative guidance with features like tremor filtering, and postoperative data analysis for performance evaluation. Additionally, Wansi Medical offers the VAS COACH, a virtual reality surgical training system, and develops its own consumable materials to complement its robotic systems.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 14.7/100
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Mar 2023 | $14M | $55M | Nuoyu Capital · CAS Investment Management | ↗ |
Growth signals
Latest recorded traffic for Beijing Wansi Medical Technology is 10 monthly website visits, down 92.9% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Beijing Wansi Medical Technology in its local ecosystem
The Beijing Wansi Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- NCNuoyu Capital
CAS Investment Management
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beijing Wansi Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beijing Wansi Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.